Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
BioConferenceLive

Helium-Free, Bench-Top MRI Scanner Draws Interest at Meetings

By BiotechDaily International staff writers
Posted on 21 May 2013
Ultra-compact, helium-free, preclinical, bench-top magnetic resonance imaging (MRI) scanners have been designed for preclinical imaging of lab animals.

The MR Solutions presented the new scanner at the American Association for Cancer Research (AACR) annual meeting in Washington DC (USA), on April 6-10, 2013, and the International Society for Magnetic Resonance in Medicine (ISMRM) annual meeting in Salt Lake City (UT, USA), on April 20-26, 2013. The new technology spurred a lot of interest for the participants.

Dr. David Taylor, CEO of MR Solutions (Guildford, UK), said, “We were overwhelmed by the interest in this new scanner one of a range to follow soon. We were repeatedly told it was a game changer; producing high quality images without compromise and able to fit within an existing laboratory at a price which is more than competitive.”

MR Solutions, developed the world’s first commercial 3T scanner late in 2012, and in January 2013, introduced two larger bore machines to complete the range. The smaller two of the new scanners, the 16-cm bore, is available now (3T) while the other two machines—31-cm 3T and 72-cm 1.5T—will be available by the end of 2013; orders for these units are already in the works. The new range of three scanners will be able to scan from small to medium-sized animals.

The advantages of these technologic advances are: (1) the scanners provide excellent soft tissue contrast and molecular imaging capabilities. (2) They are very cost-effective as there is no need for all the cryogen cooling equipment. (3) Because they have a very small stray magnetic field, the scanners can be positioned close to other imaging equipment to enable multimodality imaging on the same subject. (4) Lastly, because of the lack of liquid helium cooling and required safety equipment, the scanners are easy to install and need no expensive building alterations.

Related Links:

MR Solutions



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Microcomputed tomography images (top) and histology images (bottom) of the knees of mice fed a very high fat diet containing omega-3 fatty acid supplement (left) or only omega-6 fatty acids (right) after a knee injury. The omega-6 diet showed abnormal bone remodeling and calcified tissue formation in the joint (white arrow). The omega-6 diet also showed significant loss of cartilage (red staining, yellow arrowhead) and increased joint inflammation (Photo courtesy of Duke University).

Dietary Omega-3 Fatty Acids Moderate Severity of Osteoarthritis in a Mouse Model

Researchers working with an osteoarthritis (OA) obese mouse model found that the fat content of the animals' diet contributed more to the development or arrest of OA than did body weight.... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.